Exicureincis A Clinical Stage Biotechnology Company Focused On Developing Nucleic Acid Therapies That Target Rna For Various Health Conditionsincluding Neurological Disordersinflammatory Diseasesand Genetic Disordersthe Company Is Headquartered In Skokieillinoisand Operates A 30 000 Sqftfacility Dedicated To In House Drug Discovery And Development The Core Of Exicure S Technology Is Its Spherical Nucleic Acidsnaplatformwhich Structures Nucleic Acids Into Three Dimensional Architecturesthis Innovative Approach Aims To Enhance Cellular Uptake And Improve The Effectiveness Of Genetic Therapiesexicure S Pipeline Includes Programs In Preclinical And Clinical Stageswith A Focus On Addressing Rare Diseases And Conditions Such As Hair Loss Exicure Collaborates With Academic And Pharmaceutical Institutions To Advance Its Sna Technologythe Company Is Actively Engaged In Research And Developmentwith A Commitment To Addressing Significant Therapeutic Needs
